Treatment-associated survival outcomes in real-world patients with de novo metastatic triple-negative breast cancer: Age as a significant treatment effect-modifier-Reference-Cited by-同舟云学术

Treatment-associated survival outcomes in real-world patients with de novo metastatic triple-negative breast cancer: Age as a significant treatment effect-modifier

Published:2022-01 Issue:1 Volume:121 Page:319-328
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Chung Wei-Pang^ORCID,Yang Chun-Ting,Chen Hsuan-Ying,Su Ching-Yen,Su Hsin-Wei,Ou Huang-Tz^ORCID

Funder

Taiwan Ministry of Science and Technology

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Triple-negative breast cancer;Foulkes;N Engl J Med,2010

3. Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design;Kassam;Clin Breast Canc,2009

4. Triple-negative breast cancer: role of specific chemotherapy agents;Isakoff;Canc J,2010

5. Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials;Al-Batran;Br J Canc,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ovarian stimulation response and fertility outcomes in patients with breast cancer across different stages, grades, and hormone receptor status for fertility preservation;Journal of the Formosan Medical Association;2024-08

2. Effects of Sacituzumab on Breast Cancer: Target Therapy;Biomedical Research Bulletin;2023-12-29

3. The effect of chemotherapy on survival in oldest old patients with nonmetastatic triple negative breast cancer: A populationbased observational study;Journal of Clinical Pharmacy and Therapeutics;2022-09-29

4. Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer;Scientific Reports;2022-01-14